Home / Resources / Protocol Development and Study Design
Resources
VIEW BY TOPIC
Allergy
Autoimmune and Inflammation
Biometrics
Biostatistics
Cell and Gene Therapy
cell therapies
cell therapy
Central Nervous System
Chemistry, Manufacturing, and Controls (CMC)
Clinical Pharmacology Modeling and Simulation
Clinical Trial Operations
COVID-19
Data Management
Decentralized Clinical Trials
Depression
Dosing
Drug Development
Emerging Trends
GxP Compliance
Infectious Disease and Vaccine
Inspection Readiness
Manufacturing
Medical Writing
neuro
Neuroscience
Nonclinical
oncology
Oncology-Hematology
Other
Patient Recruitment
Pediatric
Pharmacokinetics / Pharmacodynamics
Pharmacovigilance
Preclinical
Preclinical Development
Project Management
Protocol Development and Study Design
Publishing and Submissions
Rare Disease and Orphan Drugs
Regulatory
Regulatory Affairs
Regulatory and Drug Development Consulting
Study Startup and Feasibility
Topic: Protocol Development and Study Design

Case Study
Case Study – Clinical QT Prolongation Assessment
View More

Industry Featured Article
Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success
View More

Blog
Optimizing Your Clinical Development Plan: Strategies for Biotech Success
View More

Industry Featured Article
Patient-Centric Approach To Accelerating Clinical Trials
View More

Blog
How to Overcome Challenges in Combination Immunotherapy Clinical Trials
View More

Blog
Long-Term Follow-Up for CGT Trials: Best Practices to Operationalize
View More
Blog
The Role of Statisticians in Study Design and Why to Engage them Early
View More
Webinar
Benefits of Bayesian Dose Escalation Designs for Oncology Studies
View More

Guide
A Snapshot of Gap Analysis
View More

Blog
The Essential Role of the CMC Expert in Drug Development
View More

Blog
Anticipating Obstacles to Approval Before Your Early Phase Oncology Study: Four Critical Areas to Consider
View More
Blog
How to Choose Sites for Cancer Trials: Central and Eastern Europe
View More